Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 3, 2016, Pages 459-470

  Zhang, Lei ^a   Liu, Ming ^a   Jiang, Hong ^a   Yu, Ying ^a   Yu, Peng ^a   Tong, Rui ^a   Wu, Jian ^a   Zhang, Shuning ^a   Yao, Kang ^a   Zou, Yunzeng ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Heart failure; High mobility group box 1; Hypertrophy; Pressure overload

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HIGH MOBILITY GROUP B1 PROTEIN; ISOATRIAL NATRIURETIC PEPTIDE; HMGB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEART CELL CULTURE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC PARAMETERS; HISTOLOGY; INFLAMMATION; MALE; MECHANICAL STRESS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL CULTURE; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; HEART FAILURE; HMGB1 PROTEIN; HYPERTENSION; MALE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN TRANSPORT; RATS; STRESS, PHYSIOLOGICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84958618695     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12743     Document Type: Article

References (41)

1. Frey N, Katus HA, Olson EN, et al. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004; 109: 1580-9.
2. Drazner MH. The progression of hypertensive heart disease. Circulation. 2011; 123: 327-34.
3. Sun M, Chen M, Dawood F, et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007; 115: 1398-407.
4. Verma SK, Krishnamurthy P, Barefield D, et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation. 2012; 126: 418-29.
5. Higashikuni Y, Tanaka K, Kato M, et al. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1beta upregulation via nuclear factor kappaB activation. J Am Heart Assoc. 2013; 2: e000267.
6. Hock R, Furusawa T, Ueda T, et al. HMG chromosomal proteins in development and disease. Trends Cell Biol. 2007; 17: 72-9.
7. Lange SS, Mitchell DL, Vasquez KM. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage. Proc Natl Acad Sci USA. 2008; 105: 10320-5.
8. Rovere-Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004; 5: 825-30.
9. Takahashi K, Fukushima S, Yamahara K, et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation. 2008; 118: S106-14.
10. Kohno T, Anzai T, Naito K, et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res. 2009; 81: 565-73.
11. Su FF, Shi MQ, Guo WG, et al. High-mobility group box 1 induces calcineurin-mediated cell hypertrophy in neonatal rat ventricular myocytes. Mediators Inflamm. 2012; 2012: 805149.
12. Funayama A, Shishido T, Netsu S, et al. Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure. Cardiovasc Res. 2013; 99: 657-64.
13. Jia Z, Xue R, Liu G, et al. HMGB1 Is involved in the protective effect of the PPAR alpha agonist fenofibrate against cardiac hypertrophy. PPAR Res. 2014; 2014: 541394.
14. Zou Y, Li J, Ma H, et al. Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol. 2011; 51: 821-9.
15. Zou Y, Liang Y, Gong H, et al. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy. Hypertension. 2011; 58: 1099-110.
16. Limana F, Germani A, Zacheo A, et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res. 2005; 97: e73-83.
17. 2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Mol Cell Biochem. 2011; 347: 21-8.
18. Zhou N, Li L, Wu J, et al. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Biochem Biophys Res Commun. 2010; 397: 263-9.
19. You J, Wu J, Jiang G, et al. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. J Cardiovasc Pharmacol. 2013; 61: 142-51.
20. Ling S, Sun Q, Li Y, et al. CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A. Circulation. 2012; 126: 3028-40.
21. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta. 2010; 1799: 101-13.
22. Klune JR, Dhupar R, Cardinal J, et al. HMGB1: endogenous danger signaling. Mol Med. 2008; 14: 476-84.
23. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005; 5: 331-42.
24. Erlandsson Harris H, Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol. 2004; 34: 1503-12.
25. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999; 285: 248-51.
26. Sobajima J, Ozaki S, Uesugi H, et al. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin Exp Immunol. 1998; 111: 402-7.
27. Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005; 201: 1135-43.
28. Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000; 165: 2950-4.
29. Kitahara T, Takeishi Y, Harada M, et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res. 2008; 80: 40-6.
30. Limana F, Esposito G, D'Arcangelo D, et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS ONE. 2011; 6: e19845.
31. Oozawa S, Mori S, Kanke T, et al. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J. 2008; 72: 1178-84.
32. Zhou X, Hu X, Xie J, et al. Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: involvement of Wnt signaling activation. J Biomed Biotechnol. 2012; 2012: 743879.
33. Andrassy M, Volz HC, Igwe JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 2008; 117: 3216-26.
34. Xu H, Yao Y, Su Z, et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-&alpha/JNK. Am J Physiol Heart Circ Physiol. 2011; 300: H913-21.
35. Frolkis I, Gurevitch J, Yuhas Y, et al. Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia. J Am Coll Cardiol. 2001; 37: 316-22.
36. Yamauchi-Takihara K, Ihara Y, Ogata A, et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 1995; 91: 1520-4.
37. 2-induced cardiomyocyte death through suppression of high-mobility group box 1. Mol Cell Biochem. 2012; 364: 263-9.
38. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003; 65: 45-79.
39. Opie LH, Commerford PJ, Gersh BJ, et al. Controversies in ventricular remodelling. Lancet. 2006; 367: 356-67.
40. Tzeng HPFJ, Vallejo JG, Dong JW, et al. Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes. Am J Physiol Heart Circ Physiol. 2008; 294: H1490-6.
41. Hagiwara S, Iwasaka H, Uchino T, et al. High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study. Circ J. 2008; 72: 1012-7.